09/02/2026
๐ช๐ฒ ๐ฎ๐ฟ๐ฒ ๐ฝ๐ฟ๐ผ๐๐ฑ ๐๐ผ ๐ฎ๐ป๐ป๐ผ๐๐ป๐ฐ๐ฒ ๐๐ต๐ฒ ๐น๐ฎ๐๐ป๐ฐ๐ต ๐ผ๐ณ ๐ฅ๐ถ๐๐ฒ๐ธยฎ ๐ฃ๐น๐๐ (๐ข๐บ๐ฒ๐ฝ๐ฟ๐ฎ๐๐ผ๐น๐ฒ / ๐ฆ๐ผ๐ฑ๐ถ๐๐บ ๐๐ถ๐ฐ๐ฎ๐ฟ๐ฏ๐ผ๐ป๐ฎ๐๐ฒ) ๐ถ๐ป ๐๐ต๐ฒ ๐๐ถ๐ป๐ด๐ฑ๐ผ๐บ ๐ผ๐ณ ๐ฆ๐ฎ๐๐ฑ๐ถ ๐๐ฟ๐ฎ๐ฏ๐ถ๐ฎ.
At Julphar, we recognize our responsibility as a key healthcare partner in Saudi Arabia, therefore, this launch marks an important milestone in our commitment to advancing gastroenterology care and improving patient outcomes across the Kingdom.
๐ฅ๐ถ๐๐ฒ๐ธยฎ Plus is designed to deliver reliable acid suppression, addressing key clinical challenges in GERD and related conditions. Its introduction adds meaningful value across the healthcare ecosystem.
As part of this launch, three scientific symposia were successfully held across the Kingdom, led by eminent experts in the field of gastroenterology. These scientific gatherings brought together healthcare professionals to:
- Discuss unmet needs in acid-related disorders.
- Review the scientific rationale behind OmeprazoleโSodium Bicarbonate combinations.
- Share real-world clinical experience and best practices.
- Reinforce evidence-based, patient-centric treatment decisions.
The launch of ๐ฅ๐ถ๐๐ฒ๐ธยฎ Plus reflects our ongoing dedication to science, partnership, and patient care โ and it is only the beginning of what we aim to deliver to the Saudi healthcare community.